Failed conservative management of cervical pregnancy despite falling beta-HCG

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 41, Issue 3, 2001, Pages 346-347

  Weston, G ^a   Kashyap, R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; METHOTREXATE;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHRONIC DISEASE; CONSERVATIVE TREATMENT; CURETTAGE; ECTOPIC PREGNANCY; ENDOMETRITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LAPAROTOMY; PRIORITY JOURNAL; TREATMENT FAILURE; UTERUS MYOMA; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, THERAPEUTIC; ADULT; CERVIX UTERI; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; METHOTREXATE; PREGNANCY; PREGNANCY, ECTOPIC; TREATMENT FAILURE;

EID: 0034864735     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2001.tb01246.x     Document Type: Article

References (9)

1. Cervical pregnancy - A conservative stepwise approach
2. Cervical pregnancy: Past and future
3. Conservative treatment of cervical pregnancy by curettage and local prostaglandin injection
4. Efficacy of methotrexate treatment in viable and nonviable cervical pregnancies
5. Prognostic factors for an unsatisfactory primary methotrexate treatment of cervical pregnancy: A quantitative review
6. A cervical ectopic pregnancy managed by medical treatment and angiographic embolization
7. Cervical pregnancy: Case reports and a current literature review
8. Cervical pregnancy treated with a single intravenous administration of methotrexate plus oral folinic acid
9. Are serum human chorionic gonadotropin clearance curves of use in monitoring methotrexate treatment in cervical pregnancy?